Republican · U.S. House · North Carolina, District 14
Latest filing Feb 20, 2026
Yes. Tim Moore disclosed 4 purchases of Genprex (GNPX) stock between Oct 29, 2025 and Feb 5, 2026, in STOCK Act reports. Added together, the disclosed ranges come to $18K-$95K.
Yes. Tim Moore disclosed 4 purchases of Genprex (GNPX) stock between Oct 29, 2025 and Feb 5, 2026, in STOCK Act reports. Added together, the disclosed ranges come to $18K-$95K.
How big were Tim Moore's Genprex trades?
STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $18K-$95K.
Did Tim Moore make these Genprex trades personally?
Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.
Does Tim Moore still own Genprex stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did Tim Moore report these trades?
The latest filing is dated Feb 20, 2026. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.
Loading